View Older Stories View More Recent Stories

Jun 29, 2015 05:31PM Viggle Announces Pricing of $4.2 Million Underwritten Sale of Common Stock to a Single Institutional Investor
Jun 29, 2015 04:05PM Ritter Pharmaceuticals, Inc. Announces Closing of $20,000,000 Initial Public Offering
Jun 29, 2015 09:02AM Blue Earth (BBLU) Enters 1.67M Common Stock, Warrants Direct Offering
Jun 29, 2015 09:00AM Blue Earth Announces $2 Million Registered Direct Offering
Jun 25, 2015 04:33PM Immune Pharma (IMNP) Announces Date to Commence Bertilimumab Phase II Bullous Pemphigoid Trial
Jun 25, 2015 04:30PM Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid
Jun 24, 2015 11:21AM Ritter Pharmaceuticals (RTTR) IPO Opens Flat
Jun 24, 2015 09:53AM Ritter Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
Jun 23, 2015 08:57AM Chardan Capital Markets Upgrades Avalanche Biotechnologies (AAVL) to Neutral
Jun 23, 2015 06:30AM Chardan Capital Starts Signal Genetics (SGNL) at Buy; MyPRS Test Could See Big Demand
Jun 19, 2015 03:35PM Ritter Pharmaceuticals (RTTR) Amends IPO Filing; Plans to Offer 4M Shares and Sees Price of $5/Share
Jun 18, 2015 10:36AM Notable Analyst Rating Changes 6/18: (JNPR) (HOG) (AMC) Upgraded; (RATE) (LUV) (NMBL) Downgraded
Jun 18, 2015 09:34AM Pre-Open Stock Movers 06/18: (LMNS) (DGLY) (BMRN) Higher; (HERO) (RATE) (ORCL) Lower (more...)
Jun 18, 2015 08:39AM Chardan Capital Starts VistaGen Therapeutics (VSTA) at Buy; Positive on AV-101 as Antidepressant Sans Ketamine Side Effects
Jun 18, 2015 08:30AM Chardan Capital Markets Starts Axovant Sciences (AXON) at Sell; RVT-101 Remains Overrated
Jun 18, 2015 08:16AM Chardan Capital Markets Starts Digital Ally (DGLY) at Buy; FirstVu Should be Key Source of Growth
Jun 16, 2015 09:42AM Chardan Capital Trims PT on Profire Energy (PFIE) to $1.80; FY16 Outlook 'Sharply' Lower than Expected
Jun 16, 2015 08:25AM Chardan Capital Markets Downgrades Avalanche Biotechnologies (AAVL) to Sell
Jun 10, 2015 10:06AM Esperion Therapeutics (ESPR) Price Target Lowered to $50 at Chardan
Jun 9, 2015 10:09AM Chardan Capital Markets Upgrades MaxLinear (MXL) to Buy
Jun 3, 2015 03:28PM Chardan Capital Boosts PT on Ambarella (AMBA) to $90; Stock Continues Defying Conventional Wisdom
Jun 2, 2015 04:59PM 22nd Century Group Announces Closing of $6 Million Registered Direct Offering
Jun 1, 2015 04:05PM StemCells, Inc. Announces Closing of Over-Allotment Option
May 29, 2015 10:22AM Notable Analyst Rating Changes 5/29: (MX) (CPRT) Upgraded; (HIMX) (ANF) (URI) Downgraded
May 29, 2015 09:27AM Pre-Open Stock Movers 05/29: (TBIO) (HRTX) (NQ) Higher; (FRO) (SPLK) (CYBR) Lower (more...)
May 29, 2015 08:53AM UPDATE: Chardan Capital Markets Cuts Himax Technologies (HIMX) to Sell; Samsung Moving to AMOLED Would be Huge Blow
May 29, 2015 08:08AM Chardan Capital Markets Starts Amicus Therapeutics (FOLD) at Buy
May 29, 2015 07:33AM 22nd Century Group (XXII) Enters 6M Common Stock, 3M Warrants Registered Direct Offering
May 29, 2015 07:30AM 22nd Century Group Announces $6 Million Registered Direct Offering
May 22, 2015 10:25AM Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded
May 22, 2015 08:11AM Chardan Capita Starts Esperion Therapeutics (ESPR) at Sell; Post-IPO Run Leads to Unfavorable Risk-Reward
May 22, 2015 08:09AM Chardan Capital Markets Starts Esperion Therapeutics (ESPR) at Sell
May 20, 2015 07:30AM REGENXBIO Secures $70.5 Million in a Mezzanine Financing
May 20, 2015 07:30AM REGENXBIO Secures $70.5 Million in a Mezzanine Financing
May 18, 2015 10:14AM Chardan Capital Lifts PT on Immune Pharma (IMNP) to $6 Following Q1 Report; AmiKet Appears on Track
May 14, 2015 09:29AM Camtek Ltd (CAMT) Prices 4.3M Common Offering at $2.85/Share
May 14, 2015 09:25AM Camtek Prices Underwritten Public Offering of Ordinary Shares
May 14, 2015 09:25AM CORRECTION - Camtek Ltd: Camtek Prices Underwritten Public Offering of Ordinary Shares
May 8, 2015 02:33AM NeuroVive Pharmaceutical: NeuroVive Completes Share Issue Raising SEK 70 Million for the Preparation of CicloMulsion®’s Clinical Trial in the US and Commercialization in Europe
May 7, 2015 08:39AM Chardan Capital Markets Starts U.S. Geothermal (HTM) at Neutral
May 5, 2015 07:56AM Chardan Capital Markets Upgrades CEVA Inc. (CEVA) to Buy
May 1, 2015 08:43AM Chardan Capital Markets Starts Check-Cap (CHEK) at Buy
Apr 29, 2015 04:05PM StemCells, Inc. Announces Closing of $25 Million Public Offering
Apr 29, 2015 10:47AM Notable Analyst Rating Changes 4/29: (LLY) (VOD) (UPS) Upgraded; (GLW) (ETR) (NOV) Downgraded
Apr 29, 2015 08:50AM Chardan Capital Markets Starts Lion Biotechnologies (LBIO) at Buy, PT $30
Apr 28, 2015 02:57PM New C Media Partnership Demonstrates YOU On Demand's (YOD) Desire to Diversify - Chardan Capital
Apr 26, 2015 03:33PM MassRoots Partners with Seed-to-Sale System Flowhub; Crosses 300 Dispensaries on Network
Apr 24, 2015 10:41AM Notable Analyst Rating Changes 4/24: (MAT) (TEL) (CVC) Upgraded; (BBY) (NKE) (GM) Downgraded
Apr 24, 2015 10:16AM Smoofi Announces Agreement With Licensed Cultivator in Colorado
Apr 24, 2015 09:28AM StemCells (STEM) Prices Common, Warrants Offering at $0.70/Unit
View More Recent Stories View Older Stories